FDA Matters logo
  • Blog
  • About
  • Media
Truth-Telling: FDA User Fee Edition

Truth-Telling: FDA User Fee Edition

by Steven Grossman | May 2, 2025 | Short Takes and Updates

After 50 years in Washington, I have no expectation of being told the truth by government officials—elected or appointed. I like to think I have seen it all—shading the truth, burying the truth, plausibly deniable truth, and sometimes things entirely made up and...
Truth-Telling: FDA User Fee Edition

The American People in the Hands of an Indifferent Government

by Steven Grossman | Apr 29, 2025 | Short Takes and Updates

Several decades ago, when I was a Senate staffer, I observed that I could spend the entire Gross Domestic Product on the good ideas that people brought to us. I soon learned that lawmaking requires a substantial amount of restraint and a lot of prioritizing. Those are...
Truth-Telling: FDA User Fee Edition

How Many People Still Work for FDA & Other FDA Thoughts

by Steven Grossman | Apr 25, 2025 | Short Takes and Updates

FDA’s responsibilities have not changed since January 20th. However, its capacity to carry out its duties has been meaningfully reduced by the Administration’s downsizing. We should all be able to agree on that. It has not been clear how many people still work...
Truth-Telling: FDA User Fee Edition

FDA and Politics: An Unhealthy Combination

by Steven Grossman | Apr 22, 2025 | Short Takes and Updates

Dr. Makary is a physician, healthcare quality and outcomes researcher, and self-styled iconoclast. When he accepted the Commissioner position in November 2024[1], I am sure he believed that Trump 2.0 would be a hospitable place to harness those personal attributes in...
Truth-Telling: FDA User Fee Edition

Leaked FY 26 FDA Budget Document Explained

by Steven Grossman | Apr 17, 2025 | Short Takes and Updates

There is a document widely-circulated this morning that purports to be the OMB passback to HHS of the draft proposed FY 26 HHS President’s budget request. It includes proposed numbers for FDA funding for the coming fiscal year. It is still subject to negotiation...
Truth-Telling: FDA User Fee Edition

Rx for FDA: An Agenda for the Commissioner

by Steven Grossman | Apr 15, 2025 | Short Takes and Updates

While FDA’s responsibilities have not changed, its capacity to perform its duties has been significantly reduced. After subtracting approximately 4,500 employees[1] from the agency’s 19,000 employee workforce, it cannot possibly sustain its heavy...
« Older Entries
Next Entries »

Recent Posts

  • The FDA’s Century-Long Campaign to Assure Safe Manufacturing (Part 2)
  • The FDA’s Century-Long Campaign to Assure Safe Drug Manufacturing (Part 1)
  • A Marathon, Not a Sprint: The Long Road to Becoming the Next FDA Commissioner
  • Firing Dr. Makary Solves No Problems….BUT Opens the Door for More Orderly Management and Decision-Making
  • Spotlight: The Partnership for Safe Medicines (PSM)

Recent Comments

No comments to show.
FDA Matters logo

 ©2009-2026 FDA Matters | FDA Matters does not report the news….we provide analysis of what’s behind the news.

We sometimes use artificial intelligence in drafting columns, primarily using Claude AI and Microsoft Co-Pilot. We review and verify all findings, interpretations, and final wording.